Link to this page
Physician Data Query
Last uploaded:
August 27, 2019
Jump to:
| Preferred Name | maraviroc | |
| Synonyms |
Celsentri Selzentry |
|
| Definitions |
A C-C chemokine receptor type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C73144" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C73144" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000696304 |
|
| altLabel |
Celsentri Selzentry
|
|
| CAS Registry |
376348-65-1
|
|
| cui |
C3275195 C1667052 C1964465
|
|
| DATE FIRST PUBLISHED |
2011-02-24
|
|
| Date last modified |
2015-08-14
|
|
| definition |
A C-C chemokine receptor type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C73144" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C73144" NCI Thesaurus)
|
|
| LT |
TRD
|
|
| NCI ID |
C73144
|
|
| notation |
CDR0000696304
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
maraviroc
|
|
| tui |
T109 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping